BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., a privately held healthcare company focused on the application of its novel proteomics technology to life science research and healthcare diagnostics, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2014. Byron Hewett, Chief Executive Officer, will discuss the company’s goals and progress in a presentation scheduled to begin at 8:00am PST (11:00am EST).
SomaLogic, Inc., is a privately held protein biomarker discovery, life science tools and clinical diagnostics company based in Boulder, Colo. The company's mission is to use its proprietary aptamer-based proteomic technology to develop a wide range of enhanced protein-analysis tools and reagents for life sciences, to facilitate protein biomarker discovery and validation for therapeutic applications, and to develop and commercialize clinical diagnostic products aimed at improving health care by offering timely and accurate health information to physicians and their patients. Further information about SomaLogic can be found at www.somalogic.com.